Aortic Valve Replacement Devices Market
The market for Aortic Valve Replacement Devices was estimated at $8.2 billion in 2024; it is anticipated to increase to $15.6 billion by 2030, with projections indicating growth to around $26.5 billion by 2035.
Global Aortic Valve Replacement Devices Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Aortic Valve Replacement Devices industry revenue is expected to be around $9.2 billion in 2025 and expected to showcase growth with 11.2% CAGR between 2025 and 2034. Incorporating bioengineering and medical advancements have resulted in the creation of these devices that are reshaping heart valve procedures by offering treatment alternatives to an expanding base and showcasing remarkable enhancements, in patient outcomes and quality of life.
Heart valve replacement devices for the aorta are innovations tailored to replace a defective aortic valve in the human heart with features such as compatibility with the bodys biology and long lasting performance, in natural conditions.
Market Key Insights
- The Aortic Valve Replacement Devices market is projected to grow from $8.2 billion in 2024 to $23.8 billion in 2034. This represents a CAGR of 11.2%, reflecting rising demand across Therapeutic Correction of Aortic Valve Disease, Mitigating Rheumatic Heart Disease Impact and Geriatric Care.
- Boston Scientific Corporation, Artivion Inc., Edwards Lifesciences Corporation are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Aortic Valve Replacement Devices market and are expected to observe the growth CAGR of 8.2% to 11.8% between 2024 and 2030.
- Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 10.8% to 14.0%.
- Transition like Shift to Minimally Invasive Procedures is expected to add $616 million to the Aortic Valve Replacement Devices market growth by 2030.
- The Aortic Valve Replacement Devices market is set to add $15.6 billion between 2024 and 2034, with manufacturer targeting Aortic Regurgitation & Congenital Valve Disease Application/Indication projected to gain a larger market share.
- With
rising prevalence of heart disorders, and
advancements in technology, Aortic Valve Replacement Devices market to expand 189% between 2024 and 2034.
